Oxeclosporin

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameOxeclosporin
Drug Alias NameTigderimusSDZ-IMM-125IMM-125
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionImmunosuppressants
TargetsNot applicable
Therapy Area/IndicationsAsthmaHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsAsthmaHematologic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A